SOPHiA GENETICS (SOPH) Finished Goods (2020 - 2021)
SOPHiA GENETICS recorded quarterly Finished Goods of $87000.0 in Q4 2021, down 31.5% quarter-over-quarter from $127000.0 in Q4 2020, and down 31.5% year-over-year from $127000.0 in Q4 2020.
SOPHiA GENETICS's Finished Goods history runs 2 years deep, the most recent figure standing at $87000.0 for Q4 2021.
- In Q4 2021, Finished Goods fell 31.5% year-over-year to $87000.0; the TTM figure through Dec 2021 stood at $87000.0 (down 31.5% YoY), while the FY2021 annual figure was $87000.0, down 31.5% from the prior year.
- Finished Goods came in at $87000.0 for Q4 2021 at SOPHiA GENETICS, down from $127000.0 in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $127000.0 in Q4 2020 to a low of $87000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | SOPHiA GENETICS | 24.12 Mn | -46.17 Mn | 14.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 87,000.00 |
| Dec 31, 2020 | 127,000.00 |